CIK 0001509745 · Non-accelerated filer<br>Smaller reporting company
CYPHERPUNK TECHNOLOGIES INC.
Sign in to watch- Ticker
- CYPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 274412575
- Phone
- 617 252 4343
- Business address
- 47 THORNDIKE STREET, SUITE B1-1, CAMBRIDGE, MA, 02142
- Former names
- LEAP THERAPEUTICS, INC., Dekkun Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $888,900
- in 3 filings
Net −$888,900. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-12 | McEvoy William Patrick III Chief Investment Officer | Option exercise | +4,938,801 | $0.00 | $5K | 29,793,414 |
| 2026-10-12 | McEvoy William Patrick III Chief Investment Officer | Option exercise · Pre-Funded Warrant (Right to Buy) | −4,938,801 | $0.52 | $2.6M | 97,229,007 |
| 2026-10-12 | Winklevoss Capital Fund, LLC 10% owner | Option exercise | +4,938,801 | $0.00 | $5K | 29,793,414 |
| 2026-10-12 | Winklevoss Capital Fund, LLC 10% owner | Option exercise · Pre-Funded Warrant (Right to Buy) | −4,938,801 | $0.52 | $2.6M | 97,229,007 |
| 2026-09-25 | Oei Khing Djien Director | Sale | −168,750 | $3.92 | $662K | 0 |
| 2026-09-23 | Martin Patricia A. Director | Sale | −50,000 | $3.86 | $193K | 118,750 |
| 2026-08-26 | Dietz Thomas John Director | Sale | −20,000 | $1.72 | $34K | 132,500 |
| 2026-08-21 | Zhang Kevin Head of Mining | Grant or award · Restricted Stock Units | −2,000,000 | 2,000,000 | ||
| 2026-08-17 | McEvoy William Patrick III Chief Investment Officer | Option exercise | +16,570,852 | $0.00 | $17K | 24,854,613 |
| 2026-08-17 | McEvoy William Patrick III Chief Investment Officer | Option exercise · Pre-Funded Warrant (Right to Buy) | −16,570,852 | $0.52 | $8.6M | 58,877,766 |
| 2026-08-17 | McEvoy William Patrick III Chief Investment Officer | Other acquisition · Pre-Funded Warrant (Right to Buy) | +43,290,042 | $0.77 | $33.3M | 102,167,808 |
| 2026-08-17 | Winklevoss Capital Fund, LLC 10% owner | Option exercise | +16,570,852 | $0.00 | $17K | 24,854,613 |
| 2026-08-17 | Winklevoss Capital Fund, LLC 10% owner | Option exercise · Pre-Funded Warrant (Right to Buy) | −16,570,852 | $0.52 | $8.6M | 58,877,766 |
| 2026-08-17 | Winklevoss Capital Fund, LLC 10% owner | Other acquisition · Pre-Funded Warrant (Right to Buy) | +43,290,042 | $0.77 | $33.3M | 102,167,808 |
| 2026-07-01 | Richard Christian M Director | Grant or award · Restricted Stock Units | −75,000 | 75,000 | ||
| 2026-07-01 | Oei Khing Djien Director | Grant or award · Restricted Stock Units | −100,000 | 100,000 | ||
| 2026-07-01 | Dietz Thomas John Director | Grant or award · Restricted Stock Units | −100,000 | 100,000 | ||
| 2026-07-01 | Martin Patricia A. Director | Grant or award · Restricted Stock Units | −75,000 | 75,000 | ||
| 2026-07-01 | LI WILLIAM Director | Grant or award · Restricted Stock Units | −75,000 | 75,000 | ||
| 2026-07-01 | ONSI DOUGLAS E CEO,CFO,Pres.,GC,Treas.&Sec. | Grant or award · Restricted Stock Units | −1,000,000 | 1,000,000 |
Page 1 of 18 · 348 trades